Ginkgo Bioworks
Ginkgo Bioworks is a leading synthetic biology company that partners with organizations across various industries to harness the power of biology. Their mission is to make biology easier to engineer, enabling the development of innovative solutions in agriculture, biopharma, industrial biotechnology, and more. Ginkgo's platform combines advanced automation, data analytics, and a vast library of genetic assets to accelerate research and development, optimize production processes, and reduce costs. They are revolutionizing industrial processes with biological solutions that lower costs, open new markets, valorize waste streams, and create sustainable supply chains.
Industries
Nr. of Employees
Very Large (1000+)
Ginkgo Bioworks
27 Drydock Avenue, 8th Floor, Boston, MA 02210
Products
Modular automation platform (RAC-based systems)
Hardware blueprint and deployed systems for modular, reconfigurable automation enabling end-to-end biological workflows.
NGS automation workflow package
Miniaturized, automated NGS library-prep workflow adapted for automated platforms to enable cost-efficient sequencing verification at scale.
AI/ML model platform and Model API
Hosted model access and tooling to support model-driven design and prediction for biological engineering tasks.
High-throughput dataset products (Datapoints)
Curated dataset offerings for applications such as antibody developability and functional genomics intended to support model training and R&D programs.
Modular automation platform (RAC-based systems)
Hardware blueprint and deployed systems for modular, reconfigurable automation enabling end-to-end biological workflows.
NGS automation workflow package
Miniaturized, automated NGS library-prep workflow adapted for automated platforms to enable cost-efficient sequencing verification at scale.
AI/ML model platform and Model API
Hosted model access and tooling to support model-driven design and prediction for biological engineering tasks.
High-throughput dataset products (Datapoints)
Curated dataset offerings for applications such as antibody developability and functional genomics intended to support model training and R&D programs.
Expertise Areas
- Cell engineering
- Lab automation and workflow orchestration
- High-throughput screening
- Genomic data generation and annotation
Key Technologies
- Modular lab automation (reconfigurable automation carts)
- Automation control software and open messaging schemas
- High-throughput and ultra-high-throughput screening
- Next-generation sequencing (NGS) library preparation
Key People
Co-Founder & CEO
AI Researcher
AI Developer
AI Developer
Co-Founder & President
Co-Founder
Co-Founder & CEO
AI Researcher
AI Developer
AI Developer
Co-Founder & President
Co-Founder
News & Updates
Ginkgo Bioworks announced the launch of Ginkgo Datapoints, a platform for generating data to train AI models, enhancing their capabilities in synthetic biology.
Ginkgo Bioworks introduced their Model API, a tool for AI research and development in synthetic biology.
Ginkgo Bioworks is leveraging big data and AI to revolutionize enzyme engineering, enhancing the efficiency and specificity of enzyme design.
Ginkgo Bioworks announced the opening of Bioworks7, expanding their capacity in biopharmaceuticals, biomanufacturing, and mammalian programming for therapeutic applications.
Ginkgo Bioworks acquired Altar and Circularis to enhance capabilities in adaptive laboratory evolution, circular RNA, and promoter screening.
Ginkgo Bioworks helped a partner reduce the amount of exogenous enzyme needed in their manufacturing process by ten-fold, saving millions in input costs through enzyme discovery services.
Ginkgo Bioworks announced the launch of Ginkgo Datapoints, a platform for generating data to train AI models, enhancing their capabilities in synthetic biology.
Ginkgo Bioworks introduced their Model API, a tool for AI research and development in synthetic biology.
Ginkgo Bioworks is leveraging big data and AI to revolutionize enzyme engineering, enhancing the efficiency and specificity of enzyme design.
Ginkgo Bioworks announced the opening of Bioworks7, expanding their capacity in biopharmaceuticals, biomanufacturing, and mammalian programming for therapeutic applications.
Ginkgo Bioworks acquired Altar and Circularis to enhance capabilities in adaptive laboratory evolution, circular RNA, and promoter screening.
Ginkgo Bioworks helped a partner reduce the amount of exogenous enzyme needed in their manufacturing process by ten-fold, saving millions in input costs through enzyme discovery services.